Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy
- PMID: 27604170
- DOI: 10.1002/ajmg.a.37860
Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy
Abstract
Restrictive cardiomyopathy is a rare form of pediatric cardiac disease, for which the known genes include MYH7, TNNT2, TNNI3, ACTC1, and DES. We describe a pediatric proband with fatal restrictive cardiomyopathy associated with septal hypertrophy and compound heterozygosity for TNNC1 mutations (NM_003280: p.A8V [c.C23T] and p.D145E [c.C435A]). This association between restrictive cardiomyopathy and TNNC1 mutations was strengthened by prospective observations on the second pregnancy in the family which revealed, in the presence of the same TNNC1 genotype, prenatally diagnosed hypertrophic cardiomyopathy which evolved into restrictive cardiomyopathy, heart failure and death at the age of 9 months. Contrary to previous reports, family and population analyses showed that each of the TNNC1 variants was not pathogenic when present alone. Our results (i) confirm that genetic backgrounds of hypertrophic cardiomyopathy and restrictive cardiomyopathy overlap and (ii) indicate that TNNC1 is a likely novel gene for autosomal recessive restrictive cardiomyopathy. © 2016 Wiley Periodicals, Inc.
Keywords: TNNC1 mutation; infant; restrictive cardiomyopathy.
© 2016 Wiley Periodicals, Inc.
Similar articles
-
In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.Circ Cardiovasc Genet. 2015 Oct;8(5):653-664. doi: 10.1161/CIRCGENETICS.114.000957. Epub 2015 Aug 24. Circ Cardiovasc Genet. 2015. PMID: 26304555 Free PMC article.
-
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.J Mol Cell Cardiol. 2008 Aug;45(2):281-8. doi: 10.1016/j.yjmcc.2008.05.003. Epub 2008 May 11. J Mol Cell Cardiol. 2008. PMID: 18572189 Free PMC article.
-
A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.J Biol Chem. 2012 Sep 14;287(38):31845-55. doi: 10.1074/jbc.M112.377713. Epub 2012 Jul 18. J Biol Chem. 2012. PMID: 22815480 Free PMC article.
-
Inherited cardiomyopathies as a troponin disease.Jpn J Physiol. 2004 Aug;54(4):307-18. doi: 10.2170/jjphysiol.54.307. Jpn J Physiol. 2004. PMID: 15631686 Review.
-
Cardiac troponin mutations and restrictive cardiomyopathy.J Biomed Biotechnol. 2010;2010:350706. doi: 10.1155/2010/350706. Epub 2010 Jun 8. J Biomed Biotechnol. 2010. PMID: 20617149 Free PMC article. Review.
Cited by
-
Cardiomyopathy: pathogenesis and therapeutic interventions.MedComm (2020). 2024 Oct 25;5(11):e772. doi: 10.1002/mco2.772. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39465141 Free PMC article. Review.
-
A MYH7 variant in a five-generation-family with hypertrophic cardiomyopathy.Front Genet. 2024 Feb 8;15:1306333. doi: 10.3389/fgene.2024.1306333. eCollection 2024. Front Genet. 2024. PMID: 38389574 Free PMC article.
-
Transcriptome analysis revealed potential genes involved in thermogenesis in muscle tissue in cold-exposed lambs.Front Genet. 2022 Oct 21;13:1017458. doi: 10.3389/fgene.2022.1017458. eCollection 2022. Front Genet. 2022. PMID: 36338953 Free PMC article.
-
Genotype-Phenotype Associations with Restrictive Cardiomyopathy Induced by Pathogenic Genetic Mutations.Rev Cardiovasc Med. 2022 May 25;23(6):185. doi: 10.31083/j.rcm2306185. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077162 Free PMC article. Review.
-
Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.Int J Mol Sci. 2019 Sep 6;20(18):4381. doi: 10.3390/ijms20184381. Int J Mol Sci. 2019. PMID: 31489928 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous